PBGENE-DMD aims to deliver sustained muscle function improvement for DMD patients with mutations between exons 45 and 55.
To address the pressing demands of non-invasive early screening for critical diseases and precise micro-trace monitoring of industrial pollutants, ultra-sensitive detection of volatile organic ...
TRexBio Doses First Patient with Moderate-to-Severe Atopic Dermatitis in Phase 1b Clinical Trial of TRB-061, a TNFR2 Agonist ...
16h
Newron Reports a Pause of Enrollment of New Study Participants in US Centers of ENIGMA-TRS 2 Study
Pause of enrollment limited to US sites in ENIGMA-TRS 2; Global ENIGMA-TRS 1 study continues with over 400 patients enrolled. Ad hoc announcement pursuant to Art. 53 LR. MILAN & M ...
In the realm of pulse power capacitors, dielectric energy storage materials are undeniably the "heart." As global demand surges for rapid ...
Denovo Biopharma, a pioneer in applying precision medicine in central nervous system (CNS) diseases, today announced that the U.S. Patent and Trademark Office issued U.S. patent number 12,612,261, ...
Experts discuss insomnia disorder during menopause, health risks, diagnostic gaps, and emerging treatments including orexin ...
A comprehensive 2026 evaluation uncovering the reality of the liquid weight management formula, examining the data behind the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results